Skip to main content
. 2020 Jun 2;7(3):247–256. doi: 10.3233/JND-190466

Fig.3.

Fig.3

Annual numbers of: (A) new patients genetically diagnosed with SMA and (B) SMA births* for the years 1995 to 2018. Following the description of the newly discovered SMN1 gene in 1995 and the introduction of Spinraza in 2018, extreme numbers were recorded (A). *Based on the Date Of Birth of positive SMA cases of the cohort.